20 August 2025
Image Credits: Steriline
Steriline has been existing in India straight with its own secondary since 2022, considers the Indian and Asian industry to be very crucial for its development, and constantly focuses on development-oriented resolutions that fulfil the requirements of the local pharmaceutical sector, while working in the direction of a more sustainable future.
The Indian headquarters of Steriline is rising and has approximately doubled the number of workers since it opened, with an open-minded balance between technical specialists (devoted mostly to line fixing and after-sales assistance) and marketable staff, who are concentrating on selling solutions and facilities.
The Pharma Pro&Pack Expo 2025 is more than just an occasion; it catalyzes alteration in the pharmaceutical engineering segment. This leading platform brings together industry influential, innovators, and shareholders, permitting them to network, exchange concepts, and discover the modern progressions in pharmaceutical equipment and skill. By development association and invention, the exhibition directly helps India’s healthcare and economic imports, comprising the unworkable Aatmanirbhar Bharat inventiveness.
Steriline, which is a company extremely specialised in the production of whole aseptic packing lines for injectables and ophthalmic goods for worldwide pharmaceutical companies, will display for the second successive year at Pharma Pro&Pack Expo, a significant trade show in India devoted to machinery for the handling and packaging of goods in the pharmaceutical and biotechnological segments.
Federico Fumagalli, Steriline’s CSO, expressed,
“We are satisfied to be contributing again with an opinion in the Pharma Pro&Pack Expo. For Steriline, India is considered a fundamental industry, both for antique and noticeably strategic details, as confirmed by our initial office in Mumbai 3 years ago and by the constant investment the business is making in this way.”
20 August 2025
20 August 2025
19 August 2025
19 August 2025